mr 2034 has been researched along with lithium chloride in 1 studies
Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (lithium chloride) | Trials (lithium chloride) | Recent Studies (post-2010) (lithium chloride) |
---|---|---|---|---|---|
48 | 0 | 0 | 3,883 | 45 | 1,152 |
Protein | Taxonomy | mr 2034 (IC50) | lithium chloride (IC50) |
---|---|---|---|
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6.53 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barg, J; Levy, R; Nah, SY; Saya, D; Vogel, Z | 1 |
1 other study(ies) available for mr 2034 and lithium chloride
Article | Year |
---|---|
Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Cell Communication; Cells, Cultured; Cytosol; DNA; Dose-Response Relationship, Drug; Embryo, Mammalian; Ganglia, Spinal; Inositol Phosphates; Kinetics; Lithium Chloride; Neurons; Pertussis Toxin; Pyrrolidines; Rats; Receptors, Opioid, kappa; Spinal Cord; Thymidine; Time Factors; Tritium; Virulence Factors, Bordetella | 1993 |